gerd glp 1 What is the treatment for gastroesophageal reflux disease (GERD) in patients using Glucagon-like peptide (GLP)-1 analogues? Zepbound and GERD: Managing Reflux

Particularly, one study concluded significantly different relative risk estimates between people aged 75 versus 6675 years (1.22 versus 0.64) [24], and the other study concluded comparable relative risk estimates between people aged 75 versus 6575 years (0.83 versus 0.76) [23]

ProMotility and prescription anti-nausea medications are available as backup strategies, but most patients respond well to dietary and pacing adjustments first

The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities

Autoimmune illnesses can produce persistent inflammation, which can exacerbate oxidative stress

Sources MedlinePlus